Stage IIIA Colorectal Cancer AJCC v8 Recruiting Phase 1 / 2 Trials for Abemaciclib (DB12001)
| Indication | Status | Phase |
|---|---|---|
| DBCOND0109857 (Stage IIIA Colorectal Cancer AJCC v8) | Recruiting | 1 / 2 |
| clinicaltrials.gov Identifier | Title | Purpose | Drugs |
|---|---|---|---|
| NCT04616183 | LY3214996 and Cetuximab Alone or in Combination With Abemaciclib for the Treatment of Unresectable or Metastatic Colorectal Cancer | Treatment |